MYCELX Technologies Valuation
| MYX Stock | 37.50 1.50 4.17% |
At this time, the firm appears to be overvalued. MYCELX Technologies owns a latest Real Value of USD34.44 per share. The recent price of the firm is USD37.5. Our model forecasts the value of MYCELX Technologies from analyzing the firm fundamentals such as Return On Asset of -0.25, operating margin of (0.61) %, and Profit Margin of (0.40) % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.9962 | Enterprise Value 8.6 M | Enterprise Value Ebitda (9.50) | Price Sales 1.0336 | Forward PE 12.5 |
Overvalued
Today
Please note that MYCELX Technologies' price fluctuation is very steady at this time. Calculation of the real value of MYCELX Technologies is based on 3 months time horizon. Increasing MYCELX Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MYCELX stock is determined by what a typical buyer is willing to pay for full or partial control of MYCELX Technologies. Since MYCELX Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MYCELX Stock. However, MYCELX Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 37.5 | Real 34.44 | Hype 37.5 | Naive 38.06 |
The real value of MYCELX Stock, also known as its intrinsic value, is the underlying worth of MYCELX Technologies Company, which is reflected in its stock price. It is based on MYCELX Technologies' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MYCELX Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MYCELX Technologies helps investors to forecast how MYCELX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MYCELX Technologies more accurately as focusing exclusively on MYCELX Technologies' fundamentals will not take into account other important factors: MYCELX Technologies Cash |
|
MYCELX Technologies Total Value Analysis
MYCELX Technologies is now forecasted to have takeover price of 8.56 M with market capitalization of 9.14 M, debt of 607 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MYCELX Technologies fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.56 M | 9.14 M | 607 K |
MYCELX Technologies Investor Information
About 19.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 2.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MYCELX Technologies recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. Based on the key indicators related to MYCELX Technologies' liquidity, profitability, solvency, and operating efficiency, MYCELX Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.MYCELX Technologies Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MYCELX Technologies has an asset utilization ratio of 104.98 percent. This indicates that the Company is making USD1.05 for each dollar of assets. An increasing asset utilization means that MYCELX Technologies is more efficient with each dollar of assets it utilizes for everyday operations.MYCELX Technologies Ownership Allocation
MYCELX Technologies secures a total of 24.36 Million outstanding shares. 30% of MYCELX Technologies outstanding shares are owned by institutions. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.MYCELX Technologies Profitability Analysis
The company reported the revenue of 10.91 M. Net Loss for the year was (3.71 M) with profit before overhead, payroll, taxes, and interest of 3.27 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MYCELX Technologies' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MYCELX Technologies and how it compares across the competition.
About MYCELX Technologies Valuation
The stock valuation mechanism determines MYCELX Technologies' current worth on a weekly basis. Our valuation model uses a comparative analysis of MYCELX Technologies. We calculate exposure to MYCELX Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MYCELX Technologies's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.9 M | 6 M |
Complementary Tools for MYCELX Stock analysis
When running MYCELX Technologies' price analysis, check to measure MYCELX Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MYCELX Technologies is operating at the current time. Most of MYCELX Technologies' value examination focuses on studying past and present price action to predict the probability of MYCELX Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MYCELX Technologies' price. Additionally, you may evaluate how the addition of MYCELX Technologies to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |